Earnings & Reporting

Hudbay's acquisition of Arizona Sonoran creates a massive copper district, aiming to fuel the US green transition amid market jitters and local scrutiny.

With a 33% revenue surge, Orezone Gold is funding a transformative expansion into Canada, diversifying away from its core West African operations.

Following a 22% stock plunge after a bleak 2026 forecast, Syensqo's top shareholder, Solvac, publicly vows support and close monitoring of the situation.

Silvano Fashion Group's 2025 results reveal a sharp 39.5% drop in operating profit and shrinking margins, raising concerns despite a stronger balance sheet.

Chart Industries reports strong 2025 orders driven by new energy markets, offsetting a dip in Q4, as it prepares for its acquisition by Baker Hughes.

Taiga Building Products posts a Q4 loss after a major asset write-down tied to the U.S. market, revealing surprising operational strength amid industry headwinds.

The biotech firm's stock surged after announcing a massive share repurchase, a bold move balancing shareholder value with its high-stakes R&D pipeline.

Following a year of stable sales but a reported loss, MTI executives will face investors to outline growth plans in sustainability and advanced materials.

Avante Corp. readies its Q3 investor call, with all eyes on its tech-driven growth, niche market dominance, and recent financial performance.

As UFP Technologies preps for a key investor conference, its stellar growth, strategic acquisitions, and vital role in the MedTech supply chain are in focus.

Quanta System is ditching distributors for a direct US operation in North Carolina, aiming to shake up the competitive surgical and urology laser market.

Dycom Industries will detail its role in the digital revolution at key investor conferences, backed by record earnings and a major data center acquisition.

As Summit Midstream sets its Q4 earnings date, all eyes are on whether recent acquisitions and strong gas trends can solidify its financial recovery.

Fulgent Genetics reports revenue growth but faces a pivotal year with a major customer loss, betting its future on strategic acquisitions and a promising drug pipeline.

A major Q1 loss, driven by massive restructuring costs, marks a pivotal moment as the bank sheds retail to focus on commercial under a new owner.

More men are swapping sun loungers for stress management. A new survey reveals a cultural shift toward 'reset' holidays. What does this mean for travel?

The Mexican pharma giant saw sales fall in 2025 but improved margins, strategically clearing inventory and reinvesting savings for a planned 2026 recovery.

The infrastructure giant posted a 12.2% EBITDA jump fueled by North American highways and a record construction backlog, solidifying its US-focused strategy.

The Illinois-based bank crushed Q4 estimates with a 62.5% profit jump, outperforming sector trends through strong interest income and strategic growth.

High Liner Foods posts higher Q4 sales but faces shrinking profits from tariffs and acquisition costs. Can new products and efficiencies turn the tide?